BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2851560)

  • 21. Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.
    Quickel KE; Selden R; Caldwell JR; Nora NF; Schaffner W
    Appl Microbiol; 1971 Sep; 22(3):446-50. PubMed ID: 4330318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaphylaxis after application of topical bacitracin-neomycin powder.
    Bommarito L; Mietta S; Cadario G
    Ann Allergy Asthma Immunol; 2015 Jul; 115(1):74-5. PubMed ID: 25935430
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
    Gilbert M
    J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical mupirocin in the treatment of bacterial skin infections.
    Rumsfield J; West DP; Aronson IK
    Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the bacterial ocular surface microbiome in clinically normal horses before and after treatment with topical neomycin-polymyxin-bacitracin.
    Scott EM; Arnold C; Dowell S; Suchodolski JS
    PLoS One; 2019; 14(4):e0214877. PubMed ID: 30943258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
    White DG; Collins PO; Rowsell RB
    J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 3 Topical Treatments against Ulcerative Dermatitis in Mice with a C57BL/6 Background.
    Michaud CR; Qin J; Elkins WR; Gozalo AS
    Comp Med; 2016 Apr; 66(2):100-4. PubMed ID: 27053563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple antibiotic spray application to umbilical cords.
    Elias-Jones AC
    Early Hum Dev; 1986 Jun; 13(3):299-302. PubMed ID: 3013579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperatively administered antibiotics. Their effect of bacterial counts of the eyelids.
    Whitney CR; Anderson RP; Allansmith MR
    Arch Ophthalmol; 1972 Feb; 87(2):155-60. PubMed ID: 4333409
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of a topical triple-antibiotic spray to reduce morbidity from pelvic infection after gynecologic operations.
    Wright VC; Hatch LA; Lanning NM
    Can J Surg; 1980 Jul; 23(4):366-9, 372. PubMed ID: 7417900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
    Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Smart" polymer enhances the efficacy of topical antimicrobial agents.
    De Silva CC; Israni N; Zanwar A; Jagtap A; Leophairatana P; Koberstein JT; Modak SM
    Burns; 2019 Sep; 45(6):1418-1429. PubMed ID: 31230802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of topical antimicrobial agents on the human neutrophil respiratory burst.
    Hansbrough JF; Zapata-Sirvent RL; Cooper ML
    Arch Surg; 1991 May; 126(5):603-8. PubMed ID: 1850590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment: topical mupirocin.
    Pappa KA
    Drug Intell Clin Pharm; 1987 May; 21(5):466. PubMed ID: 3107962
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention by topical antibiotics of experimental wound infections produced by enteric bacteria.
    Glotzer DJ; Goodman WS; Geronimus LH
    Surg Forum; 1969; 20():54-5. PubMed ID: 4315510
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical antibiotic treatment of impetigo with mupirocin.
    Eells LD; Mertz PM; Piovanetti Y; Pekoe GM; Eaglstein WH
    Arch Dermatol; 1986 Nov; 122(11):1273-6. PubMed ID: 3096221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Campoli-Richards DM
    Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined topical and systemic antibiotic prophylaxis in experimental wound infection.
    Bergamini TM; Lamont PM; Cheadle WG; Polk HC
    Am J Surg; 1984 Jun; 147(6):753-6. PubMed ID: 6731687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.